World Journal of Emergency Surgery (Mar 2023)

A prospective multicentre study evaluating the outcomes of the abdominal wall dehiscence repair using posterior component separation with transversus abdominis muscle release reinforced by a retro-muscular mesh: filling a step

  • Tamer A. A. M. Habeeb,
  • Abdulzahra Hussain,
  • Vishal Shelat,
  • Massimo Chiaretti,
  • Jose Bueno-Lledó,
  • Alfonso García Fadrique,
  • Abd-Elfattah Kalmoush,
  • Mohamed Elnemr,
  • Khaled Safwat,
  • Ahmed Raafat,
  • Tamer Wasefy,
  • Ibrahim A. Heggy,
  • Gamal Osman,
  • Waleed A. Abdelhady,
  • Walid A. Mawla,
  • Alaa A. Fiad,
  • Mostafa M. Elaidy,
  • Wessam Amr,
  • Mohamed I. Abdelhamid,
  • Ahmed Mahmoud Abdou,
  • Abdelaziz I. A. Ibrahim,
  • Muhammad Ali Baghdadi

DOI
https://doi.org/10.1186/s13017-023-00485-9
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background This study aimed to evaluate the results of posterior component separation (CS) and transversus abdominis muscle release (TAR) with retro-muscular mesh reinforcement in patients with primary abdominal wall dehiscence (AWD). The secondary aims were to detect the incidence of postoperative surgical site occurrence and risk factors of incisional hernia (IH) development following AWD repair with posterior CS with TAR reinforced by retromuscular mesh. Methods Between June 2014 and April 2018, 202 patients with grade IA primary AWD (Björck's first classification) following midline laparotomies were treated using posterior CS with TAR release reinforced by a retro-muscular mesh in a prospective multicenter cohort study. Results The mean age was 42 ± 10 years, with female predominance (59.9%). The mean time from index surgery (midline laparotomy) to primary AWD was 7 ± 3 days. The mean vertical length of primary AWD was 16 ± 2 cm. The median time from primary AWD occurrence to posterior CS + TAR surgery was 3 ± 1 days. The mean operative time of posterior CS + TAR was 95 ± 12 min. No recurrent AWD occurred. Surgical site infections (SSI), seroma, hematoma, IH, and infected mesh occurred in 7.9%, 12.4%, 2%, 8.9%, and 3%, respectively. Mortality was reported in 2.5%. Old age, male gender, smoking, albumin level < 3.5 gm%, time from AWD to posterior CS + TAR surgery, SSI, ileus, and infected mesh were significantly higher in IH. IH rate was 0.5% and 8.9% at two and three years, respectively. In multivariate logistic regression analyses, the predictors of IH were time from AWD till posterior CS + TAR surgical intervention, ileus, SSI, and infected mesh. Conclusion Posterior CS with TAR reinforced by retro-muscular mesh insertion resulted in no AWD recurrence, low IH rates, and low mortality of 2.5%. Trial registration Clinical trial: NCT05278117.

Keywords